Rankings
▼
Calendar
IDXX Q3 2024 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena
IDXX
IDEXX Laboratories, Inc.
$48B
Q3 2024 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$976M
+6.6% YoY
Gross Profit
$596M
61.1% margin
Operating Income
$304M
31.2% margin
Net Income
$233M
23.9% margin
EPS (Diluted)
$2.80
QoQ Revenue Growth
-2.8%
Cash Flow
Operating Cash Flow
$220M
Free Cash Flow
$192M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$3.4B
Total Liabilities
$1.7B
Stockholders' Equity
$1.6B
Cash & Equivalents
$309M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$976M
$916M
+6.6%
Gross Profit
$596M
$548M
+8.8%
Operating Income
$304M
$275M
+10.4%
Net Income
$233M
$212M
+9.7%
Revenue Segments
Product
$568M
58%
Service
$408M
42%
Geographic Segments
UNITED STATES
$638M
65%
EMEA
$199M
20%
Asia Pacific
$81M
8%
CANADA
$37M
4%
Latin America
$21M
2%
← FY 2024
All Quarters
Q4 2024 →